IL1B and metabolic dysfunction-associated steatotic liver disease: Hepatic IL-1β expression and blood CRP concentration were increased in the HFD-induced NAFLD group after combined biogenic amine administration compared with HFD + CMC and NCD + CMC groups (Figure 4).